Case File №
#VI-2026-0407
Verified Peptides
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
45 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Semaglutide | A Great | 4 | 8.3 | 7.9 | 8.9 | 13 Feb 2025 |
| Tirzepatide | A Great | 4 | 7.2 | 7.0 | 7.5 | 13 Feb 2025 |
| Melanotan II | B Good | 4 | 7.1 | 6.0 | 8.4 | 19 Feb 2025 |
| Retatrutide | B Good | 4 | 7.0 | 5.9 | 9.7 | 13 Feb 2025 |
| PT-141 | B Good | 4 | 6.5 | 5.9 | 7.0 | 16 Mar 2025 |
| BPC-157 | B Good | 5 | 6.7 | 5.2 | 9.0 | 14 Jan 2025 |
| Ipamorelin | C Okay | 4 | 5.6 | 4.9 | 6.9 | 13 Feb 2025 |
| CJC-1295 | C Okay | 5 | 6.8 | 4.1 | 8.4 | 14 Jan 2025 |
| Abaloparatide | X N/A | 2 | 7.2 | 6.9 | 7.6 | 17 May 2026 |
| ACE-031 | X N/A | 2 | 7.0 | 5.9 | 8.1 | 19 Jan 2026 |
| Anadrol (Oxymetholone) | X N/A | 1 | 4.0 | 4.0 | 4.0 | 14 Jan 2025 |
| Anavar (Oxandrolone) | X N/A | 2 | 10.0 | 10.0 | 10.0 | 25 May 2026 |
| Arimidex (Anastrozole) | X N/A | 1 | 6.7 | 6.7 | 6.7 | 24 Apr 2025 |
| Aromasin (Exemestane) | X N/A | 3 | 7.1 | 3.5 | 9.2 | 17 May 2026 |
| BAM15 | X N/A | 3 | 5.2 | 3.8 | 6.3 | 23 May 2026 |
| Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | X N/A | 3 | 6.3 | 4.5 | 8.8 | 24 May 2026 |
| Cerebrolysin | X N/A | 3 | 8.3 | 7.3 | 10.0 | 24 May 2026 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 3 | 7.4 | 6.7 | 8.2 | 26 Jan 2026 |
| Dapoxetine | X N/A | 1 | 10.0 | 10.0 | 10.0 | 16 Mar 2025 |
| DHB (1-Test Cyp) Oral | X N/A | 2 | 7.0 | 5.7 | 8.3 | 25 May 2026 |
| Dihexa | X N/A | 2 | 6.5 | 6.1 | 6.9 | 23 May 2026 |
| EPO | X N/A | 2 | 6.9 | 6.2 | 7.6 | 21 May 2026 |
| KPV Oral | X N/A | 2 | 8.6 | 7.8 | 9.4 | 26 Jan 2026 |
| KPV | X N/A | 3 | 6.7 | 5.7 | 8.2 | 26 Jan 2026 |
| Letrozole | X N/A | 2 | 7.8 | 7.6 | 7.9 | 21 May 2026 |
| Lipo-B 216mg | X N/A | 2 | 7.6 | 6.3 | 8.8 | 19 Jan 2026 |
| Liraglutide | X N/A | 1 | 7.8 | 7.8 | 7.8 | 27 Feb 2025 |
| Minoxidil Oral | X N/A | 3 | 8.8 | 8.3 | 9.4 | 24 May 2026 |
| MOTS-C | X N/A | 2 | 7.5 | 6.6 | 8.4 | 23 May 2026 |
| MT-1 | X N/A | 2 | 7.8 | 7.6 | 8.0 | 17 May 2026 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 3 | 6.3 | 4.7 | 7.2 | 21 May 2026 |
| NAD+ | X N/A | 2 | 7.5 | 7.5 | 7.6 | 26 Jan 2026 |
| Oxytocin Acetate | X N/A | 3 | 7.1 | 6.0 | 8.0 | 24 May 2026 |
| P21 | X N/A | 1 | 6.9 | 6.9 | 6.9 | 24 Apr 2025 |
| Primobolan Oral (Methenolone Acetate) | X N/A | 2 | 7.0 | 6.1 | 8.0 | 17 May 2026 |
| Selank 10mg + Semax 10mg Blend | X N/A | 3 | 5.9 | 5.7 | 6.2 | 17 May 2026 |
| Selank | X N/A | 2 | 6.8 | 5.3 | 8.4 | 23 May 2026 |
| Semax | X N/A | 2 | 8.2 | 8.1 | 8.3 | 19 Jan 2026 |
| Super Shred | X N/A | 2 | 6.7 | 5.4 | 8.0 | 23 May 2026 |
| Tamoxifen (Nolvadex) Raw | X N/A | 2 | 7.8 | 6.3 | 9.3 | 17 May 2026 |
| Tamoxifen (Nolvadex) | X N/A | 2 | 6.3 | 5.8 | 6.8 | 24 May 2026 |
| Testosterone Phenylpropionate Raw | X N/A | 2 | 6.8 | 6.0 | 7.5 | 17 May 2026 |
| Tirzepatide Raw | X N/A | 1 | 7.9 | 7.9 | 7.9 | 16 Mar 2025 |
| Tren Hex | X N/A | 1 | 7.1 | 7.1 | 7.1 | 13 Feb 2025 |
| Winstrol (Stanozolol) | X N/A | 3 | 6.3 | 5.3 | 7.4 | 23 May 2026 |
Exhibit II
Evidence Log
85 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | BAM15 | 4.0 C | 50mg | 46.4mg | -7.1% | 96.95% | ljg69c | Lab C | Community |
| 24 May 2026 | Dihexa | 4.0 C | 10mg | 11.8mg | +17.8% | 98.89% | nm0mju | Lab F | Public |
| 24 May 2026 | Tirzepatide Raw | 8.4 A | 100g | 99.7g | -0.3% | 98.36% | kvcwrq | Lab F | Community |
| 24 May 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 7.1 A | 2mg | 2.3mg | +13.6% | 99.04% | g1zhrr | Lab F | Community |
| 24 May 2026 | MOTS-C | 8.4 A | 10mg | 10.0mg | -0.3% | 96.98% | l8pxkl | Lab A | Public |
| 24 May 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 6.3 A | 10mg | 12.4mg | +23.8% | 96.47% | bxzdyy | Lab G | Public |
| 24 May 2026 | Dapoxetine | 10.0 A | 10mg | 12.2mg | +22.0% | 98.19% | z3q5vf | Lab E | Community |
| 24 May 2026 | Dihexa | 7.1 A | 100mg | 103.9mg | +3.9% | 97.23% | 90cg0u | Lab D | Community |
| 24 May 2026 | KPV Oral | 8.3 A | 10mg | 11.7mg | +16.8% | 96.94% | lujznc | Lab G | Public |
| 24 May 2026 | KPV | 7.4 A | 30mg | 33.4mg | +11.2% | 95.03% | zx8iml | Lab D | Public |
| 24 May 2026 | EPO | 7.1 A | 10mg | 12.0mg | +19.9% | 96.22% | iyv19m | Lab F | Community |
| 24 May 2026 | MT-1 | 8.5 A | 30mg | 31.3mg | +4.3% | 97.44% | 7cvs25 | Lab A | Public |
| 24 May 2026 | Primobolan Oral (Methenolone Acetate) | 8.3 A | 25mg | 23.2mg | -7.3% | 98.27% | dotsqr | Lab F | Community |
| 23 May 2026 | Oxytocin Acetate | 6.4 A | 10mg | 9.4mg | -6.2% | 99.55% | nf2sx7 | Lab D | Public |
| 23 May 2026 | Tamoxifen (Nolvadex) Raw | 7.5 A | 1g | 1.0g | -1.5% | 98.25% | ra3ymk | Lab G | Public |
| 23 May 2026 | Abaloparatide | 8.2 A | 2mg | 2.1mg | +6.7% | 97.43% | e0no1r | Lab D | Public |
| 23 May 2026 | KPV | 8.0 A | 50mg | 60.8mg | +21.6% | 97.20% | xn6odp | Lab B | Community |
| 21 May 2026 | Aromasin (Exemestane) | 7.9 A | 100mg | 103.0mg | +3.0% | 98.60% | omzje8 | Lab A | Public |
| 21 May 2026 | Cerebrolysin | 6.6 A | 2mg | 1.7mg | -13.5% | 97.94% | q5cg3r | Lab F | Public |
| 21 May 2026 | EPO | 8.6 A | 15mg | 18.5mg | +23.5% | 96.50% | 2y9wip | Lab G | Public |
| 21 May 2026 | KPV | 7.4 A | 50mg | 62.4mg | +24.8% | 99.39% | fe0nrl | Lab G | Community |
| 21 May 2026 | Tamoxifen (Nolvadex) Raw | 7.4 A | 500g | 605.2g | +21.0% | 96.83% | nuo9pf | Lab A | Public |
| 21 May 2026 | Minoxidil Oral | 7.9 A | 100mg | 115.1mg | +15.1% | 95.23% | ublax6 | Lab G | Public |
| 21 May 2026 | Minoxidil Oral | 9.6 A | 20mg | 24.3mg | +21.4% | 97.45% | dfkwpw | Lab B | Community |
| 21 May 2026 | Tren Hex | 6.3 A | 200mg/ml | 200.9mg/ml | +0.4% | 95.37% | su3wu2 | Lab B | Public |
| 20 May 2026 | Arimidex (Anastrozole) | 6.7 A | 20mg | 20.1mg | +0.5% | 97.85% | slxxif | Lab C | Public |
| 20 May 2026 | Aromasin (Exemestane) | 8.7 A | 50mg | 49.0mg | -1.9% | 95.88% | hkyd2a | Lab G | Public |
| 20 May 2026 | MT-1 | 8.0 A | 20mg | 24.6mg | +22.8% | 96.69% | 9sk17h | Lab E | Public |
| 19 May 2026 | Anavar (Oxandrolone) | 9.2 A | 50mg | 56.4mg | +12.7% | 96.29% | znv871 | Lab E | Public |
| 19 May 2026 | Lipo-B 216mg | 7.4 A | 250mg/ml | 286.2mg/ml | +14.5% | 97.82% | shhlrg | Lab B | Public |
| 19 May 2026 | Liraglutide | 7.1 A | 15mg | 17.5mg | +16.3% | 99.66% | gcp6e3 | Lab G | Public |
| 19 May 2026 | P21 | 5.7 B | 5mg | 5.9mg | +17.6% | 98.36% | jd82k2 | Lab G | Community |
| 17 May 2026 | Aromasin (Exemestane) | 7.3 A | 100mg | 92.8mg | -7.2% | 98.98% | 8hxc7n | Lab G | Public |
| 17 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.5 A | 30mg | 32.4mg | +7.9% | 97.17% | 4xgfx2 | Lab D | Community |
| 17 May 2026 | NAD+ | 7.3 A | 30mg | 31.6mg | +5.5% | 99.38% | wll335 | Lab E | Community |
| 17 May 2026 | Selank 10mg + Semax 10mg Blend | 7.4 A | 10mg | 9.6mg | -4.0% | 98.82% | qkq4vf | Lab B | Public |
| 17 May 2026 | Testosterone Phenylpropionate Raw | 6.7 A | 10g | 10.4g | +4.0% | 97.83% | m4fhaq | Lab E | Public |
| 29 Jan 2026 | Anavar (Oxandrolone) | 8.0 A | 100mg | 122.8mg | +22.8% | 95.01% | p6fvwi | Lab C | Community |
| 29 Jan 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 5.7 B | 200mg/ml | 245.7mg/ml | +22.8% | 97.81% | neeoe0 | Lab E | Public |
| 29 Jan 2026 | Tamoxifen (Nolvadex) | 5.3 B | 100mg | 124.3mg | +24.3% | 99.40% | nepa1i | Lab C | Community |
| 26 Jan 2026 | BAM15 | 5.1 B | 20mg | 23.8mg | +19.0% | 97.27% | t27yl4 | Lab B | Community |
| 26 Jan 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 6.0 A | 100mg/ml | 91.1mg/ml | -8.9% | 96.33% | mp6k4f | Lab D | Community |
| 26 Jan 2026 | DHB (1-Test Cyp) Oral | 6.9 A | 100mg | 103.7mg | +3.7% | 98.18% | clh1lg | Lab B | Public |
| 26 Jan 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.2 A | 5mg | 5.6mg | +12.1% | 97.94% | 92hwkt | Lab D | Community |
| 26 Jan 2026 | Winstrol (Stanozolol) | 4.0 C | 25mg | 22.2mg | -11.2% | 95.69% | 2pgutt | Lab E | Public |
| 19 Jan 2026 | BAM15 | 7.1 A | 10mg | 8.5mg | -15.0% | 99.13% | kq7eu2 | Lab C | Community |
| 7 Jan 2026 | Cerebrolysin | 8.2 A | 15mg | 15.4mg | +2.6% | 98.52% | viqpe1 | Lab A | Community |
| 7 Jan 2026 | Lipo-B 216mg | 9.0 A | 300mg/ml | 338.4mg/ml | +12.8% | 96.21% | yboeiv | Lab C | Public |
| 7 Jan 2026 | Super Shred | 5.7 B | 300mg/ml | 262.4mg/ml | -12.5% | 99.30% | cvv4yv | Lab A | Community |
| 6 Jan 2026 | Primobolan Oral (Methenolone Acetate) | 6.7 A | 100mg | 118.4mg | +18.4% | 95.43% | htqqrs | Lab G | Community |
| 6 Jan 2026 | Selank | 8.5 A | 2mg | 2.0mg | -1.9% | 97.92% | h3dnvv | Lab G | Public |
| 29 Dec 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.7 A | 20mg | 17.3mg | -13.3% | 95.38% | e3vy5y | Lab B | Public |
| 29 Dec 2025 | Semax | 7.6 A | 10mg | 8.6mg | -14.0% | 98.36% | ut4vwc | Lab E | Community |
| 12 Dec 2025 | NAD+ | 10.0 A | 2mg | 2.0mg | -1.9% | 97.18% | zngb47 | Lab D | Community |
| 12 Dec 2025 | Oxytocin Acetate | 6.4 A | 30mg | 29.4mg | -2.1% | 99.41% | v38ej7 | Lab E | Public |
| 12 Dec 2025 | Semax | 8.5 A | 10mg | 11.6mg | +15.5% | 95.10% | xebc97 | Lab G | Public |
| 12 Dec 2025 | Testosterone Phenylpropionate Raw | 6.2 A | 1g | 1.2g | +21.4% | 98.22% | 7f1azo | Lab E | Public |
| 5 Dec 2025 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 7.3 A | 15mg | 14.6mg | -3.0% | 96.02% | fpn8ar | Lab E | Community |
| 5 Dec 2025 | Tamoxifen (Nolvadex) | 5.6 B | 25mg | 24.6mg | -1.8% | 99.96% | uzuf8j | Lab E | Community |
| 23 Nov 2025 | MOTS-C | 5.6 B | 2mg | 2.3mg | +15.4% | 98.71% | okx5tg | Lab C | Public |
| 17 Nov 2025 | ACE-031 | 8.6 A | 2mg | 2.1mg | +4.3% | 99.94% | 6wbunv | Lab B | Community |
| 17 Nov 2025 | ACE-031 | 4.2 C | 10mg | 8.5mg | -14.8% | 99.06% | tuhof6 | Lab D | Public |
| 17 Nov 2025 | Letrozole | 8.1 A | 50mg | 56.9mg | +13.8% | 99.93% | ge2kym | Lab C | Public |
| 17 Nov 2025 | Minoxidil Oral | 6.6 A | 50mg | 53.2mg | +6.5% | 95.67% | xfq2er | Lab F | Public |
| 17 Nov 2025 | Super Shred | 5.6 B | 200mg/ml | 196.6mg/ml | -1.7% | 98.33% | 33pksy | Lab D | Community |
| 14 Nov 2025 | Cerebrolysin | 6.5 A | 20mg | 21.7mg | +8.5% | 98.70% | qj06er | Lab C | Public |
| 14 Nov 2025 | DHB (1-Test Cyp) Oral | 6.7 A | 100mg | 113.7mg | +13.7% | 99.57% | 2671k5 | Lab D | Community |
| 14 Nov 2025 | Letrozole | 7.8 A | 25mg | 27.4mg | +9.6% | 99.38% | 1b8ptd | Lab F | Public |
| 14 Nov 2025 | Winstrol (Stanozolol) | 5.1 B | 10mg | 10.7mg | +6.8% | 98.05% | 1zu1aw | Lab D | Community |
| 5 Nov 2025 | Anadrol (Oxymetholone) | 4.0 C | 20mg | 19.9mg | -0.5% | 96.86% | 42999e | Lab G | Community |
| 5 Nov 2025 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 6.9 A | 300mg/ml | 322.5mg/ml | +7.5% | 99.98% | qv6tlz | Lab A | Public |
| 5 Nov 2025 | KPV Oral | 9.6 A | 20mg | 17.2mg | -14.2% | 96.16% | 8t5she | Lab A | Public |
| 5 Nov 2025 | Selank 10mg + Semax 10mg Blend | 5.7 B | 10mg | 12.2mg | +21.7% | 95.28% | dpq1tq | Lab C | Public |
| 5 Nov 2025 | Selank 10mg + Semax 10mg Blend | 5.8 B | 5mg | 5.9mg | +18.1% | 97.82% | 2yu2ja | Lab B | Community |
| 4 Nov 2025 | Selank | 8.8 A | 10mg | 12.2mg | +22.3% | 98.68% | a3a4iw | Lab E | Community |
| 9 Oct 2025 | Oxytocin Acetate | 7.0 A | 30mg | 28.0mg | -6.6% | 96.36% | 92a30m | Lab F | Community |
| 3 Oct 2025 | Abaloparatide | 6.6 A | 10mg | 10.8mg | +7.9% | 96.37% | x681ok | Lab F | Public |
| 3 Oct 2025 | Winstrol (Stanozolol) | 4.9 C | 10mg | 11.3mg | +13.0% | 95.48% | lqrzp4 | Lab E | Community |
| 7 May 2025 | PT-141 | X | 7.0 | 10mg | 11.9mgwebsite | 10.48mg | -12.2% | 07-24-0710G | Violet Label / Silver Crimp / Violet Cap |
| 7 May 2025 | PT-141 | X | 6.9 | 10mg | 11.9mgwebsite | 10.55mg | -11.6% | 07-24-0710G | Violet Label / Silver Crimp / Violet Cap |
| 16 Mar 2025 | PT-141 | X | 5.9 | 10mg | 11.9mgwebsite | 10.58mg | -11.4% | 07-24-0710G | Violet Label / Silver Crimp / Violet Cap |
| 16 Mar 2025 | PT-141 | X | 6.4 | 10mg | 11.9mgwebsite | 10.88mg | -8.9% | 07-24-0710G | Violet Label / Silver Crimp / Violet Cap |
| 21 Feb 2025 | CJC-1295 | No DAC X | 6.6 | 5mg | 5.6mgwebsite | 5.59mg | -0.5% | 07-24-0505E | Purple Label / Silver Crimp / Purple Cap |
| 19 Feb 2025 | BPC-157 | X | 9.0 | 10mg | 11.4mgwebsite | 10.91mg | -3.9% | 11-24-0510E | Blue Label / Silver Crimp / Purple Cap |
| 19 Feb 2025 | CJC-1295 | No DAC X | 6.5 | 5mg | 5.6mgwebsite | 5.3mg | -5.7% | 07-24-0505E | Purple Label / Silver Crimp / Purple Cap |
— END OF EVIDENCE LOG —